BNP Paribas Financial Markets’s Sangamo Therapeutics SGMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $783 | Buy |
|
|||||
|
2025
Q1 | $945 | Buy |
|
|||||
|
2024
Q4 | $450 | Sell |
|
|||||
|
2024
Q3 | $2.69K | Hold |
|
|||||
|
2024
Q2 | $1.11K | Sell |
|
|||||
|
2024
Q1 | $48.4K | Sell |
|
|||||
|
2023
Q4 | $230K | Buy |
|
|||||
|
2023
Q3 | $104K | Buy |
|
|||||
|
2023
Q2 | $131K | Sell |
|
|||||
|
2023
Q1 | $455K | Buy |
|
|||||
|
2022
Q4 | $480K | Sell |
|
|||||
|
2022
Q3 | $962K | Buy |
|
|||||
|
2022
Q2 | $134K | Sell |
|
|||||
|
2022
Q1 | $215K | Buy |
|
|||||
|
2021
Q4 | $184K | Buy |
|
|||||
|
2021
Q3 | $192K | Buy |
|
|||||
|
2021
Q2 | $75.6K | Sell |
|
|||||
|
2021
Q1 | $369K | Buy |
|
|||||
|
2020
Q4 | $315K | Sell |
|
|||||
|
2020
Q3 | $255K | Buy |
|
|||||
|
2020
Q2 | $142K | Sell |
|
|||||
|
2020
Q1 | $381K | Sell |
|
|||||
|
2019
Q4 | $3.33M | Buy |
|
|||||
|
2019
Q3 | $172K | Buy |
|
|||||
|
2019
Q2 | $133K | Sell |
|
|||||
|
2019
Q1 | $211K | Buy |
|
|||||
|
2018
Q4 | $12.4K | Sell |
|
|||||
|
2018
Q3 | $77.9K | Sell |
|
|||||
|
2018
Q2 | $129K | Sell |
|
|||||
|
2018
Q1 | $1.79M | Buy |
|
|||||
|
2017
Q4 | $280K | Buy |
|
|||||
|
2017
Q3 | $122K | Buy |
|
|||||
|
2017
Q2 | $69K | Buy |
|
|||||
|
2017
Q1 | $2.36K | Sell |
|
|||||
|
2016
Q4 | $3.7K | Sell |
|
|||||
|
2016
Q3 | $22.2K | Buy |
|
|||||
|
2016
Q2 | $15.8K | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $132K | Buy |
|
|||||
|
2015
Q3 | $80.4K | Buy |
|
|||||
|
2015
Q2 | $64.2K | Buy |
|
|||||
|
2015
Q1 | $25.2K | Buy |
|
|||||
|
2014
Q4 | – | Sell |
|
|||||
|
2014
Q3 | $43.7K | Buy |
|
|||||
|
2014
Q2 | $4.12K | Buy |
|
|||||
|
2014
Q1 | – | Sell |
|
|||||
|
2013
Q4 | $11K | Sell |
|
|||||
|
2013
Q3 | $171K | Sell |
|
|||||
|
2013
Q2 | $146K | Buy |
|